Treatment with HNG reduced IL-17A protein levels by 48.31 % in AMD cells: P = 0.0303; AMD UN CL = 1 ± 0.1487 a.u.; AMD HNG CL = 0.5169 ± 0.1098 a.u. (Figure 4K). The gene discussed is IL17A; the disease is age-related macular degeneration.